Crossmark

Efficacy of epigenetic agents for older patients with acute myeloid leukemia and myelodysplastic syndrome in randomized controlled trials: a systematic review and network meta-analysis

Crossref DOI link: https://doi.org/10.1007/s10238-023-01041-0

Published Online: 2023-03-25

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Oh, SuA

Kim, EunYoung
Funding

Funding for this research was provided by:

Ministry of Science and ICT, South Korea (2021R1F1A1062044, 2021R1F1A1062044)

Ministry of Education (2021R1A6A1A03044296, 2021R1A6A1A03044296)
License Information

Text and Data Mining valid from 2023-03-25

Version of Record valid from 2023-03-25
More Information

Article History

Received: 25 January 2023

Accepted: 2 March 2023

First Online: 25 March 2023

Declarations

:

: The authors declare that there is no conflict of interest.

Document is current

Any future updates will be listed below